Business · 23/02/2026
FDA Clears Clonazepam Tablets for Approval
The FDA has determined that the 0.125mg and 0.25mg versions of Klonopin tablets were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of generic versions.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →